DAXXIFY (Revance Australia Pty Ltd)
Product name
DAXXIFY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 (255 working days)
Active ingredients
daxibotulinumtoxinA
Registration type
NCE/ NBE
Indication
DAXXIFY is indicated for:
- the temporary improvement in the appearance of moderate to severe glabellar linesassociated with corrugator and/or procerus muscle activity in adult patients.
- the treatment of cervical dystonia in adult patients.